Bayer (FRA:BAYN) PT Set at €61.00 by Warburg Research

Warburg Research set a €61.00 ($70.93) price objective on Bayer (FRA:BAYN) in a report published on Friday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the healthcare company’s stock.

A number of other brokerages have also recently commented on BAYN. Berenberg Bank set a €86.00 ($100.00) price target on shares of Bayer and gave the company a buy rating in a research report on Tuesday, January 14th. DZ Bank reiterated a buy rating on shares of Bayer in a research report on Thursday, January 16th. Deutsche Bank set a €70.00 ($81.40) price target on shares of Bayer and gave the company a neutral rating in a research report on Thursday, October 31st. HSBC set a €63.00 ($73.26) price target on shares of Bayer and gave the company a neutral rating in a research report on Wednesday, November 27th. Finally, UBS Group set a €110.00 ($127.91) price target on shares of Bayer and gave the company a buy rating in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have issued a buy rating to the company. The company presently has an average rating of Buy and an average price target of €79.94 ($92.95).

Shares of FRA BAYN opened at €75.50 ($87.79) on Friday. Bayer has a one year low of €91.58 ($106.49) and a one year high of €123.82 ($143.98). The firm’s 50 day simple moving average is €72.24 and its two-hundred day simple moving average is €66.52.

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Further Reading: What is the outlook for the FAANG stocks?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit